Rao, N.L.; Kotian, G.B.; Shetty, J.K.; Shelley, B.P.; Dmello, M.K.; Lobo, E.C.; Shankar, S.P.; Almeida, S.D.; Shah, S.R.
Receptor for Advanced Glycation End Product, Organ Crosstalk, and Pathomechanism Targets for Comprehensive Molecular Therapeutics in Diabetic Ischemic Stroke. Biomolecules 2022, 12, 1712.
https://doi.org/10.3390/biom12111712
AMA Style
Rao NL, Kotian GB, Shetty JK, Shelley BP, Dmello MK, Lobo EC, Shankar SP, Almeida SD, Shah SR.
Receptor for Advanced Glycation End Product, Organ Crosstalk, and Pathomechanism Targets for Comprehensive Molecular Therapeutics in Diabetic Ischemic Stroke. Biomolecules. 2022; 12(11):1712.
https://doi.org/10.3390/biom12111712
Chicago/Turabian Style
Rao, Nivedita L., Greeshma B. Kotian, Jeevan K. Shetty, Bhaskara P. Shelley, Mackwin Kenwood Dmello, Eric C. Lobo, Suchetha Padar Shankar, Shellette D. Almeida, and Saiqa R. Shah.
2022. "Receptor for Advanced Glycation End Product, Organ Crosstalk, and Pathomechanism Targets for Comprehensive Molecular Therapeutics in Diabetic Ischemic Stroke" Biomolecules 12, no. 11: 1712.
https://doi.org/10.3390/biom12111712
APA Style
Rao, N. L., Kotian, G. B., Shetty, J. K., Shelley, B. P., Dmello, M. K., Lobo, E. C., Shankar, S. P., Almeida, S. D., & Shah, S. R.
(2022). Receptor for Advanced Glycation End Product, Organ Crosstalk, and Pathomechanism Targets for Comprehensive Molecular Therapeutics in Diabetic Ischemic Stroke. Biomolecules, 12(11), 1712.
https://doi.org/10.3390/biom12111712